Corrigendum: Decreased expression of programmed death ligand-L1 by seven in absentia homolog 2 in cholangiocarcinoma enhances T-cell–mediated antitumor activity

Corrigendum: Decreased expression of programmed death ligand-L1 by seven in absentia homolog 2 in cholangiocarcinoma enhances T-cell–mediated antitumor activity

Bibliographic Details
Main Authors:	Hao Zheng, Wen-juan Zheng, Zhen-guang Wang, Yuan-ping Tao, Zhi-ping Huang, Le Yang, Liu Ouyang, Zhi-qing Duan, Yi-nuo Zhang, Bo-ning Chen, Dai-min Xiang, Gang Jin, Lu Fang, Fan Zhou, Bo Liang
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-12-01
Series:	Frontiers in Immunology
Subjects:	N6-methyladenosine METTL14 Siah2 PD-L1 immunotherapy
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2022.1093403/full

Similar Items

Decreased Expression of Programmed Death Ligand-L1 by Seven in Absentia Homolog 2 in Cholangiocarcinoma Enhances T-Cell–Mediated Antitumor Activity
by: Hao Zheng, et al.
Published: (2022-01-01)

Prognostic Implication of the m6A RNA Methylation Regulators in Rectal Cancer
by: Yajie Chen, et al.
Published: (2021-06-01)

Mettl14-mediated m6A modification enhances the function of Foxp3+ regulatory T cells and promotes allograft acceptance
by: Yanzhuo Liu, et al.
Published: (2022-10-01)

Corrigendum: Mettl14-mediated m6A modification enhances the function of Foxp3+ regulatory T cells and promotes allograft acceptance
by: Yanzhuo Liu, et al.
Published: (2022-12-01)

Emerging Roles of N6-Methyladenosine Modification in Neurodevelopment and Neurodegeneration
by: Liqi Shu, et al.
Published: (2021-10-01)

PRMT1 methylates METTL14 to modulate its oncogenic function
by: Jingchao Wang, et al.
Published: (2023-08-01)

Mettl14-mediated m6A modification is essential for visual function and retinal photoreceptor survival
by: Yeming Yang, et al.
Published: (2022-06-01)

METTL14 Inhibits Hepatocellular Carcinoma Metastasis Through Regulating EGFR/PI3K/AKT Signaling Pathway in an m6A-Dependent Manner
by: Shi Y, et al.
Published: (2020-12-01)

Genes related to N6-methyladenosine in the diagnosis and prognosis of idiopathic pulmonary fibrosis
by: Jingcheng Zhang, et al.
Published: (2023-01-01)

Insights into the Regulatory Role of m<sup>6</sup>A Epitranscriptome in Glioblastoma
by: Silvia Galardi, et al.
Published: (2020-04-01)

Metformin enhances METTL14-Mediated m6A methylation to alleviate NIT-1 cells apoptosis induced by hydrogen peroxide
by: Si-min Zhou, et al.
Published: (2024-01-01)

METTL16 predicts a favorable outcome and primes antitumor immunity in pancreatic ductal adenocarcinoma
by: Liting Lu, et al.
Published: (2022-09-01)

N6-methyladenosine-modified TRAF1 promotes sunitinib resistance by regulating apoptosis and angiogenesis in a METTL14-dependent manner in renal cell carcinoma
by: Yuanlei Chen, et al.
Published: (2022-05-01)

N(6)-adenosine-methyltransferase-14 promotes glioma tumorigenesis by repressing argininosuccinate synthase 1 expression in an m6A-dependent manner
by: You-Qing Miao, et al.
Published: (2022-01-01)

Downregulation of m6A Methyltransferase in the Hippocampus of Tyrobp–/– Mice and Implications for Learning and Memory Deficits
by: Zhanyun Lv, et al.
Published: (2022-03-01)

Mettl14-Mediated m6A Modification Facilitates Liver Regeneration by Maintaining Endoplasmic Reticulum HomeostasisSummary
by: Xiaoyue Cao, et al.
Published: (2021-01-01)

m6A Methyltransferase METTL14-Mediated Upregulation of Cytidine Deaminase Promoting Gemcitabine Resistance in Pancreatic Cancer
by: Congjun Zhang, et al.
Published: (2021-08-01)

Upregulation of METTL14 mediates the elevation of PERP mRNA N6 adenosine methylation promoting the growth and metastasis of pancreatic cancer
by: Min Wang, et al.
Published: (2020-08-01)

Mettl14 inhibits bladder TIC self-renewal and bladder tumorigenesis through N 6-methyladenosine of Notch1
by: Chaohui Gu, et al.
Published: (2019-11-01)

Transcriptome-Wide Analysis of RNA N6-Methyladenosine Modification in Adriamycin-Resistant Acute Myeloid Leukemia Cells
by: Shu Fang, et al.
Published: (2022-04-01)

METTL14-mediated Lnc-LSG1 m6A modification inhibits clear cell renal cell carcinoma metastasis via regulating ESRP2 ubiquitination
by: Danyang Shen, et al.
Published: (2022-03-01)

m6A methyltransferase METTL3 programs CD4+ T-cell activation and effector T-cell differentiation in systemic lupus erythematosus
by: Shuang Lu, et al.
Published: (2023-04-01)

Decreased expression of METTL14 predicts poor prognosis and construction of a prognostic signature for clear cell renal cell carcinoma
by: Yi Wang, et al.
Published: (2021-01-01)

METTL3-Mediated ADAMTS9 Suppression Facilitates Angiogenesis and Carcinogenesis in Gastric Cancer
by: Nuofan Wang, et al.
Published: (2022-04-01)

The m6A Methyltransferase METTL3 Is Functionally Implicated in DLBCL Development by Regulating m6A Modification in PEDF
by: Yingying Cheng, et al.
Published: (2020-08-01)

Alteration of m6A RNA Methylation in Heart Failure With Preserved Ejection Fraction
by: Beijian Zhang, et al.
Published: (2021-03-01)

Integrative analysis of m3C associated genes reveals METTL2A as a potential oncogene in breast Cancer
by: Shuai Wang, et al.
Published: (2022-10-01)

Novel insights into the m6A-RNA methyltransferase METTL3 in cancer
by: Yiqing Cai, et al.
Published: (2021-04-01)

METTL3-mediated methylation of CYP2C19 mRNA may aggravate clopidogrel resistance in ischemic stroke patients
by: Tan Quandan, et al.
Published: (2024-02-01)

Rna M6a Methylation Regulates Glycolysis of Beige Fat and Contributes to Systemic Metabolic Homeostasis
by: Yu Li, et al.
Published: (2023-09-01)

The role, mechanism, and application of RNA methyltransferase METTL14 in gastrointestinal cancer
by: Bin Shi, et al.
Published: (2022-08-01)

Aberrant METTL14 gene expression contributes to malignant transformation of benzene-exposed myeloid cells
by: Chao Wu, et al.
Published: (2024-05-01)

RNA m6A methyltransferase METTL14 promotes the procession of non‐small cell lung cancer by targeted CSF1R
by: Siying Ren, et al.
Published: (2023-01-01)

METTL14-mediated N6-methyladenosine modification of SOX4 mRNA inhibits tumor metastasis in colorectal cancer
by: Xiaoxiang Chen, et al.
Published: (2020-06-01)

Downregulation of Siah1 promotes colorectal cancer cell proliferation and migration by regulating AKT and YAP ubiquitylation and proteasome degradation
by: Zhiyuan Xiao, et al.
Published: (2020-02-01)

METTL3 regulates N6-methyladenosine modification of ANGPTL3 mRNA and potentiates malignant progression of stomach adenocarcinoma
by: Zhijin Zhang, et al.
Published: (2023-06-01)

METTL3/YTHDC1-mediated upregulation of LINC00294 promotes hepatocellular carcinoma progression
by: Rulin Zhang, et al.
Published: (2023-12-01)

Clinical and molecular significance of the RNA m6A methyltransferase complex in prostate cancer
by: Jennifer Lothion-Roy, et al.
Published: (2023-01-01)

Mechanism of m6A methyltransferase 3 in the pathogenesis of diabetic cataract
by: Si Chen, et al.
Published: (2023-08-01)

Systematic expression analysis of m6A RNA methyltransferases in clear cell renal cell carcinoma
by: Larissa Gundert, et al.
Published: (2021-11-01)